Revance Therapeutics, Inc. - COM (RVNC)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
81.8M
Holdings value Q3 2024
$424M
Value change Q3 2024
+$73.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
194
Number of buys Q3 2024
106
Number of sells Q3 2024
-93
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 81.8M $424M +$73.7M $5.19 202
2024 Q2 81.4M $209M -$16.4M $2.57 171
2024 Q1 83M $409M +$34.6M $4.92 183
2023 Q4 72.4M $636M -$58.4M $8.79 193
2023 Q3 77.7M $891M -$142M $11.47 187
2023 Q2 81.8M $2.07B +$120M $25.31 211
2023 Q1 76.5M $2.46B +$118M $32.21 218
2022 Q4 73.8M $1.36B +$97.4M $18.46 189
2022 Q3 67.6M $1.82B +$329M $27.00 179
2022 Q2 56M $774M +$10.6M $13.82 158
2022 Q1 54.5M $1.06B +$29.9M $19.50 151
2021 Q4 53M $865M -$84.6M $16.32 146
2021 Q3 54.9M $1.53B +$20.5M $27.86 156
2021 Q2 54.1M $1.6B -$17.9M $29.64 159
2021 Q1 54.8M $1.53B +$56.3M $27.95 150
2020 Q4 52.8M $1.49B +$97.4M $28.34 151
2020 Q3 49.5M $1.25B -$26.6M $25.14 153
2020 Q2 50.6M $1.23B +$33.1M $24.42 138
2020 Q1 49.4M $732M -$26.4M $14.80 126
2019 Q4 51M $828M +$133M $16.23 130
2019 Q3 42.6M $554M -$12M $13.00 107
2019 Q2 43.6M $564M +$26.8M $12.97 111
2019 Q1 41.6M $656M +$101M $15.76 110
2018 Q4 31.8M $640M +$12.3M $20.13 98
2018 Q3 34.4M $854M -$15.5M $24.85 109
2018 Q2 34.9M $957M +$13.9M $27.45 112
2018 Q1 34.2M $1.05B -$35.2M $30.80 120
2017 Q4 35M $1.25B +$169M $35.75 116
2017 Q3 27.4M $754M -$1.52M $27.55 83
2017 Q2 27.5M $727M +$33.7M $26.40 85
2017 Q1 26.3M $546M +$45.4M $20.80 76
2016 Q4 26.1M $540M +$12.2M $20.70 79
2016 Q3 28.6M $464M -$989K $16.21 74
2016 Q2 28.8M $391M +$16.9M $13.60 79
2016 Q1 27.2M $475M -$26M $17.46 82
2015 Q4 24.1M $824M +$190M $34.16 100
2015 Q3 18.5M $552M +$34.9M $29.76 75
2015 Q2 17.4M $556M +$16M $31.98 86
2015 Q1 17.5M $362M +$18.6M $20.73 68
2014 Q4 19.8M $335M +$8.32M $16.94 68
2014 Q3 15.7M $303M -$45.1M $19.33 80
2014 Q2 16.4M $556M +$155M $34.00 98
2014 Q1 11.8M $373M +$373M $31.50 65